Immunome, Inc. (IMNM)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Purnanand D. Sarma
Employees:
40
665 STOCKTON DRIVE, SUITE 300, EXTON, PA 19341
610-321-3700

Immunome, Inc. discovers and develops antibody therapeutics for oncology and infectious disease. The company was incorporated in 2006 and is headquartered in Exton, Pennsylvania.

Data derived from most recent annual or quarterly report
Market Cap 95.18 Million Shares Outstanding12.203 Million Avg 30-day Volume 88.199 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-0.36
Price to Revenue9.997 Debt to Equity0.0 EBITDA-21.933 Million
Price to Book Value16.7692 Operating Margin-222.3705 Enterprise Value11.248 Million
Current Ratio3.955 EPS Growth0.418 Quick Ratio3.922
1 Yr BETA -0.1718 52-week High/Low 9.53 / 2.2 Profit Margin-215.4435
Operating Cash Flow Growth111.1342 Free Cash Flow to Firm (FCFF) TTM 64.706 Million Free Cash Flow to Equity (FCFE) TTM-16.419 Million
Altman Z-Score-1.0678
View SEC Filings from IMNM instead.

View recent insider trading info

Immunome, Inc. YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding IMNM (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding IMNM

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

  • 3: filed on 2023-11-09 by BIENAIME JEAN JACQUES
  • 4: filed on 2023-10-31 by BARCHAS ISAAC
  • 4: filed on 2023-10-31 by BOYLAN JAMES P
  • 4: filed on 2023-10-31 by LECHLEIDER ROBERT
  • 3: filed on 2023-10-20 by LECHLEIDER ROBERT
  • 3: filed on 2023-10-12 by BARCHAS ISAAC
  • 3: filed on 2023-10-12 by ROSETT MAX
  • 3: filed on 2023-10-12 by HIGGINS JACK
  • 3: filed on 2023-10-12 by BOYLAN JAMES P
  • 4: filed on 2023-10-04 by TURNER BRUCE

    • Events (8k)

  • 8-K/A: filed on 2023-11-22:
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-11-15:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-11-09:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-11-08:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2023-10-04:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 2.01: Completion of Acquisition or Disposition of Assets
    Item 3.02: Unregistered Sales of Equity Securities
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
    Item 5.07: Submission of Matters to a Vote of Security Holders
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-09-21:
    Item 8.01: Other Events
  • 8-K: filed on 2023-08-09:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-07-05:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-06-29:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 3.02: Unregistered Sales of Equity Securities
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-06-13:
    Item 5.07: Submission of Matters to a Vote of Security Holders

    • Proposed Sales (Form 144)

    Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    BIENAIME JEAN JACQUES

    • Director
    		 0 2023-11-07 2

    BARCHAS ISAAC

    • Director
    		 0 2023-10-27 2

    BOYLAN JAMES P

    • Director
    		 0 2023-10-27 2

    LECHLEIDER ROBERT CHIEF MEDICAL OFFICER

    • Officer
    		 0 2023-10-27 2

    SIEGALL CLAY B PRESIDENT AND CEO

    • Officer
    • Director
    		 150,432 2023-10-02 2

    PRENDERGAST FRANKLYN G

    • Director
    		 60,840 2023-10-02 2

    RAPP MICHAEL

    • Director
    		 1,279,914 2023-10-02 3

    TURNER BRUCE CHIEF STRATEGY OFFICER

    • Officer
    		 0 2023-10-02 2

    HIGGINS JACK CHIEF SCIENTIFIC OFFICER

    • Officer
    		 0 2023-10-02 1

    ROSETT MAX SVP OPERATIONS

    • Officer
    		 19,856 2023-10-02 1

    LAMATTINA JOHN L

    • Director
    		 0 2023-06-08 2

    BARON RICHARD A

    • Director
    		 0 2023-06-08 1

    WAGENHEIM PHILIP

    • Director
    		 0 2023-06-08 2

    SARMA PURNANAND D PRESIDENT AND CEO

    • Officer
    • Director
    		 0 2023-06-08 1

    LEFENFELD MICHAEL

    • Director
    		 0 2023-06-08 2

    STONEMAN SANDRA G. GENERAL COUNSEL AND CLO

    • Officer
    		 0 2023-06-08 1

    GIESING DENNIS H CHIEF DEVELOPMENT OFFICER

    • Officer
    		 0 2023-06-08 1

    ROCHE CORLEEN M. CHIEF FINANCIAL OFFICER

    • Officer
    		 0 2023-06-08 1

    ROBINSON MATTHEW K CHIEF TECHNOLOGY OFFICER

    • Officer
    		 0 2023-06-08 1

    WIDLITZ MICHAEL

    • Director
    		 3,750 2021-05-28 0

    MARCOU DIANE M INTERIM CFO

    • Officer
    		 0 2020-11-30 0

    MORRIS I WISTAR III

    • 10% Owner
    		 920,939 2020-10-06 0

    FITZGERALD RICHARD F CHIEF FINANCIAL OFFICER

    • Officer
    		 0 2020-10-01 0

    MORIN MICHAEL CHIEF SCIENTIFIC OFFICER

    • Officer
    		 0 2020-10-01 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed    		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

    BIENAIME JEAN JACQUES - Director

    		2023-11-09 16:25:27 -0500 2023-11-07 A 40,696 a 40,696 direct

    LECHLEIDER ROBERT - Officer CHIEF MEDICAL OFFICER

    		2023-10-31 18:30:54 -0400 2023-10-27 A 400,000 a 400,000 direct

    BOYLAN JAMES P - Director

    		2023-10-31 18:32:27 -0400 2023-10-27 A 41,538 a 41,538 direct

    BARCHAS ISAAC - Director

    		2023-10-31 18:35:19 -0400 2023-10-27 A 41,538 a 41,538 direct

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    IMMUNOME INC IMNM 2023-12-01 22:15:04 UTC -0.3074 5.6274 800000
    IMMUNOME INC IMNM 2023-12-01 21:45:05 UTC -0.3074 5.6274 800000
    IMMUNOME INC IMNM 2023-12-01 21:15:04 UTC -0.3074 5.6274 800000
    IMMUNOME INC IMNM 2023-12-01 20:45:04 UTC -0.3074 5.6274 800000
    IMMUNOME INC IMNM 2023-12-01 20:15:04 UTC -0.4779 5.7979 800000
    IMMUNOME INC IMNM 2023-12-01 19:45:04 UTC -0.4779 5.7979 800000
    IMMUNOME INC IMNM 2023-12-01 19:15:04 UTC -0.4779 5.7979 800000
    IMMUNOME INC IMNM 2023-12-01 18:45:05 UTC -0.4779 5.7979 800000
    IMMUNOME INC IMNM 2023-12-01 18:15:03 UTC -0.4779 5.7979 800000
    IMMUNOME INC IMNM 2023-12-01 17:45:04 UTC -0.6855 6.0055 800000
    IMMUNOME INC IMNM 2023-12-01 17:15:03 UTC -0.6855 6.0055 800000
    IMMUNOME INC IMNM 2023-12-01 16:45:03 UTC -0.6855 6.0055 800000
    IMMUNOME INC IMNM 2023-12-01 16:15:04 UTC -0.6855 6.0055 800000
    IMMUNOME INC IMNM 2023-12-01 15:45:03 UTC -0.6855 6.0055 800000
    IMMUNOME INC IMNM 2023-12-01 15:15:05 UTC -0.6855 6.0055 800000
    IMMUNOME INC IMNM 2023-12-01 14:45:03 UTC -1.6076 6.9276 800000
    IMMUNOME INC IMNM 2023-12-01 14:15:04 UTC -1.6076 6.9276 800000
    IMMUNOME INC IMNM 2023-12-01 13:45:04 UTC 0.8398 4.4802 800000
    IMMUNOME INC IMNM 2023-12-01 13:15:04 UTC 0.8398 4.4802 800000
    IMMUNOME INC IMNM 2023-12-01 12:45:04 UTC 0.8398 4.4802 800000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    WhaleWisdom Logo

    Elevate your investments